After a very brief period (~48 hours) without a newly reported Middle East Respiratory Syndrome Coronavirus (MERS-CoV) case, South Korean health authorities have reported (computer translated) an additional three cases and one death.

Maureen Metcalfe; Azaibi Tamin/CDC
Maureen Metcalfe; Azaibi Tamin/CDC

The details on the new cases are as follows: A patient visited the Accident and Emergency (A & E) department of Kyung Hee University Hospital at Gangdong on June 5; a health-care worker who had contact with a confirmed case in A&E of Konkuk University Medical Center on June 6; and a health-care worker of Samsung Medical Center who had contact with another confirmed case.

This brings the total cases in the Korea outbreak to 169, including the exported case to China. The additional fatality, the 25th, was a 63-year-old male with co-morbidities.

In a somewhat related and totally unbelievable story from their neighbors to the north, North Korean state media is reporting of a pharmaceutical company, Pugang Pharmaceutical Company, that developed a vaccine called “Kumdang-2”.

This miracle vaccine, made from extracts from ginseng grown in rare earth elements, is claimed to be a cure not only against MERS, but a number of other infectious and non-infectious diseases like AIDS, Ebola and diabetes.

Fact or fiction? Look at the history of media coverage from North Korea and judge for yourself.

Related: North Korea from space: Witness the darkness that’s the Hermit Kingdom 

North Korea’s Hung Il Gong is the first ever man (boy) to land on the sun: Satire at it’s best